JOE sign up for etocs
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1677/joe.0.1690453
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (215)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delerive, P
Right arrow Articles by Staels, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delerive, P
Right arrow Articles by Staels, B
Journal of Endocrinology, Vol 169, Issue 3, 453-459
Copyright © 2001 by Society for Endocrinology

Articles

Peroxisome proliferator-activated receptors in inflammation control

P Delerive, JC Fruchart, and B Staels


Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear receptor superfamily. PPARalpha is highly expressed in liver, skeletal muscle, kidney, heart and the vascular wall. PPARgamma is predominantly detected in adipose tissue, intestine and macrophages. PPARs are activated by fatty-acid derivatives and pharmacological agents such as fibrates and glitazones which are specific for PPARalpha and PPARgamma respectively. PPARs regulate lipid and lipoprotein metabolism, glucose homeostasis, cell proliferation and differentiation, and apoptosis. PPARalpha controls intra- and extracellular lipid metabolisms whereas PPARgamma triggers adipocyte differentiation and promotes lipid storage. In addition, PPARs also modulate the inflammatory response. PPAR activators have been shown to exert anti-inflammatory activities in various cell types by inhibiting the expression of proinflammatory genes such as cytokines, metalloproteases and acute-phase proteins. PPARs negatively regulate the transcription of inflammatory response genes by antagonizing the AP-1, nuclear factor-kappaB (NF-kappaB), signal transducer and activator of transcription and nuclear factor of activated T-cells signalling pathways and by stimulating the catabolism of proinflammatory eicosanoids. These recent findings indicate a modulatory role for PPARs in inflammation with potential therapeutical applications in chronic inflammatory diseases.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Hoetzel, T. Dolinay, S. Vallbracht, Y. Zhang, H. P. Kim, E. Ifedigbo, S. Alber, A. M. Kaynar, R. Schmidt, S. W. Ryter, et al.
Carbon Monoxide Protects against Ventilator-induced Lung Injury via PPAR-{gamma} and Inhibition of Egr-1
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1223 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
X. Ruan, F. Zheng, and Y. Guan
PPARs and the kidney in metabolic syndrome
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1032 - F1047.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen, and A. M. Schols
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Eur. Respir. J., March 1, 2008; 31(3): 502 - 508.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Linard, O. Gremy, and M. Benderitter
Reduction of Peroxisome Proliferation-Activated Receptor {gamma} Expression by {gamma}-Irradiation as a Mechanism Contributing to Inflammatory Response in Rat Colon: Modulation by the 5-Aminosalicylic Acid Agonist
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 911 - 920.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Kamijo, K. Hora, K. Kono, K. Takahashi, M. Higuchi, T. Ehara, K. Kiyosawa, H. Shigematsu, F. J. Gonzalez, and T. Aoyama
PPAR{alpha} Protects Proximal Tubular Cells from Acute Fatty Acid Toxicity
J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3089 - 3100.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. T. A. Nguyen, S. Favelyukis, A.-K. Nguyen, D. Reichart, P. A. Scott, A. Jenn, R. Liu-Bryan, C. K. Glass, J. G. Neels, and J. M. Olefsky
A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways
J. Biol. Chem., November 30, 2007; 282(48): 35279 - 35292.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. Szatmari, D. Torocsik, M. Agostini, T. Nagy, M. Gurnell, E. Barta, K. Chatterjee, and L. Nagy
PPAR{gamma} regulates the function of human dendritic cells primarily by altering lipid metabolism
Blood, November 1, 2007; 110(9): 3271 - 3280.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
A. M. Lincoff, K. Wolski, S. J. Nicholls, and S. E. Nissen
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
JAMA, September 12, 2007; 298(10): 1180 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. D'Agostino, G. La Rana, R. Russo, O. Sasso, A. Iacono, E. Esposito, G. M. Raso, S. Cuzzocrea, J. Lo Verme, D. Piomelli, et al.
Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor-{alpha} Agonist, Modulates Carrageenan-Induced Paw Edema in Mice
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1137 - 1143.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. K. LeBrasseur, T.-A. S. Duhaney, D. S. De Silva, L. Cui, P. C. Ip, L. Joseph, and F. Sam
Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension
Hypertension, September 1, 2007; 50(3): 489 - 496.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. M. Hall and D. P. McDonnell
The Molecular Mechanisms Underlying the Proinflammatory Actions of Thiazolidinediones in Human Macrophages
Mol. Endocrinol., August 1, 2007; 21(8): 1756 - 1768.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. M. Perez-Ortiz, P. Tranque, M. Burgos, C. F. Vaquero, and J. Llopis
Glitazones Induce Astroglioma Cell Death by Releasing Reactive Oxygen Species from Mitochondria: Modulation of Cytotoxicity by Nitric Oxide
Mol. Pharmacol., August 1, 2007; 72(2): 407 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
B. E.J. Teunissen, P. J.H. Smeets, P. H.M. Willemsen, L. J. De Windt, G. J. Van der Vusse, and M. Van Bilsen
Activation of PPAR{delta} inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts
Cardiovasc Res, August 1, 2007; 75(3): 519 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Saika, O. Yamanaka, Y. Okada, T. Miyamoto, A. Kitano, K. C. Flanders, Y. Ohnishi, Y. Nakajima, W. W.-Y. Kao, and K. Ikeda
Effect of overexpression of ppar{gamma} on the healing process of corneal alkali burn in mice
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C75 - C86.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Zapata-Gonzalez, F. Rueda, J. Petriz, P. Domingo, F. Villarroya, A. de Madariaga, and J. C. Domingo
9-cis-Retinoic Acid (9cRA), a Retinoid X Receptor (RXR) Ligand, Exerts Immunosuppressive Effects on Dendritic Cells by RXR-Dependent Activation: Inhibition of Peroxisome Proliferator-Activated Receptor {gamma} Blocks Some of the 9cRA Activities, and Precludes Them to Mature Phenotype Development
J. Immunol., May 15, 2007; 178(10): 6130 - 6139.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
T.-A. S. Duhaney, L. Cui, M. K. Rude, N. K. Lebrasseur, S. Ngoy, D. S. De Silva, D. A. Siwik, R. Liao, and F. Sam
Peroxisome Proliferator-Activated Receptor {alpha}-Independent Actions of Fenofibrate Exacerbates Left Ventricular Dilation and Fibrosis in Chronic Pressure Overload
Hypertension, May 1, 2007; 49(5): 1084 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. A. Wohlfert, F. C. Nichols, E. Nevius, and R. B. Clark
Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) and Immunoregulation: Enhancement of Regulatory T Cells through PPAR{gamma}-Dependent and -Independent Mechanisms
J. Immunol., April 1, 2007; 178(7): 4129 - 4135.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. T. Chambers, S. M. Weber, and J. A. Corbett
PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1052 - E1061.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
V. Chintalgattu, G. S. Harris, S. M. Akula, and L. C. Katwa
PPAR-{gamma} agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts
Cardiovasc Res, April 1, 2007; 74(1): 140 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
B. N. Finck
The PPAR regulatory system in cardiac physiology and disease
Cardiovasc Res, January 15, 2007; 73(2): 269 - 277.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Kamijo, K. Hora, T. Nakajima, K. Kono, K. Takahashi, Y. Ito, M. Higuchi, K. Kiyosawa, H. Shigematsu, F. J. Gonzalez, et al.
Peroxisome Proliferator-Activated Receptor {alpha} Protects against Glomerulonephritis Induced by Long-Term Exposure to the Plasticizer Di-(2-Ethylhexyl)Phthalate
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 176 - 188.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
I. SZATMARI, E. RAJNAVOLGYI, and L. NAGY
PPAR{gamma}, a Lipid-Activated Transcription Factor as a Regulator of Dendritic Cell Function
Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 207 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
C. R. Sirtori
HDL and the progression of atherosclerosis: new insights
Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F4 - F9.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. Venteclef, J. C. Smith, B. Goodwin, and P. Delerive
Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.
Mol. Cell. Biol., September 1, 2006; 26(18): 6799 - 6807.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
G Rogler
Significance of anti-inflammatory effects of PPAR{gamma} agonists?
Gut, August 1, 2006; 55(8): 1067 - 1069.
[Full Text] [PDF]

Home page
 GutHome page
I A Leclercq, C Sempoux, P Starkel, and Y Horsmans
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats
Gut, July 1, 2006; 55(7): 1020 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
J. M. Tovar and D. B. Schering
Management of Dyslipidemia in Special Populations
Journal of Pharmacy Practice, April 1, 2006; 19(2): 63 - 78.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Sato, F. A. Moore, B. C. Kone, L. Zou, M. A. Smith, M. A. Childs, S. Moore-Olufemi, S. G. Schultz, and R. A. Kozar
Differential induction of PPAR-{gamma} by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G616 - G623.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. Paumelle, C. Blanquart, O. Briand, O. Barbier, C. Duhem, G. Woerly, F. Percevault, J.-C. Fruchart, D. Dombrowicz, C. Glineur, et al.
Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator-Activated Receptor-{alpha} via Inhibition of the Protein Kinase C Signaling Pathway
Circ. Res., February 17, 2006; 98(3): 361 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. Blaschke, Y. Takata, E. Caglayan, R. E. Law, and W. A. Hsueh
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 28 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. E Minge, N. K. Ryan, K. H. V. D. Hoek, R. L. Robker, and R. J. Norman
Troglitazone Regulates Peroxisome Proliferator-Activated Receptors and Inducible Nitric Oxide Synthase in Murine Ovarian Macrophages
Biol Reprod, January 1, 2006; 74(1): 153 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
N. F. Cariello, E. H. Romach, H. M. Colton, H. Ni, L. Yoon, J. G. Falls, W. Casey, D. Creech, S. P. Anderson, G. R. Benavides, et al.
Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver
Toxicol. Sci., November 1, 2005; 88(1): 250 - 264.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
W. E. Ackerman IV, X. L. Zhang, B. H. Rovin, and D. A. Kniss
Modulation of Cytokine-Induced Cyclooxygenase 2 Expression by PPARG Ligands Through NF{kappa}B Signal Disruption in Human WISH and Amnion Cells
Biol Reprod, September 1, 2005; 73(3): 527 - 535.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Leibovici, H. B. Grossman, C. P. Dinney, R. E. Millikan, S. Lerner, Y. Wang, J. Gu, Q. Dong, and X. Wu
Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and Survival
J. Clin. Oncol., August 20, 2005; 23(24): 5746 - 5756.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Li, N. Gokden, M. D. Okusa, R. Bhatt, and D. Portilla
Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F469 - F480.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. A. Burgess, L. E. Daugherty, T. H. Thatcher, H. F. Lakatos, D. M. Ray, M. Redonnet, R. P. Phipps, and P. J. Sime
PPAR{gamma} agonists inhibit TGF-{beta} induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1146 - L1153.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Mouthiers, A. Baillet, C. Delomenie, D. Porquet, and N. Mejdoubi-Charef
Peroxisome Proliferator-Activated Receptor {alpha} Physically Interacts with CCAAT/Enhancer Binding Protein (C/EBP{beta}) to Inhibit C/EBP{beta}-Responsive {alpha}1-Acid Glycoprotein Gene Expression
Mol. Endocrinol., May 1, 2005; 19(5): 1135 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Migita and J. Morser
15-Deoxy-{Delta}12,14-Prostaglandin J2 (15d-PGJ2) Signals Through Retinoic Acid Receptor-Related Orphan Receptor-{alpha} but Not Peroxisome Proliferator-Activated Receptor-{gamma} in Human Vascular Endothelial Cells: The Effect of 15d-PGJ2 on Tumor Necrosis Factor-{alpha}-Induced Gene Expression
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 710 - 716.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
NINDS ICH Workshop Participants
Priorities for Clinical Research in Intracerebral Hemorrhage: Report From a National Institute of Neurological Disorders and Stroke Workshop
Stroke, March 1, 2005; 36(3): e23 - e41.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. L. Schiffrin
Peroxisome proliferator-activated receptors and cardiovascular remodeling
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1037 - H1043.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Xu, M. Gen, L. Lu, J. Fox, S. O. Weiss, R. D. Brown, D. Perlov, H. Ahmad, P. Zhu, C. Greyson, et al.
PPAR-{gamma} activation fails to provide myocardial protection in ischemia and reperfusion in pigs
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1314 - H1323.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Genovese, S. Cuzzocrea, R. Di Paola, E. Mazzon, C. Mastruzzo, P. Catalano, M. Sortino, N. Crimi, A. P. Caputi, C. Thiemermann, et al.
Effect of rosiglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2 on bleomycin-induced lung injury
Eur. Respir. J., February 1, 2005; 25(2): 225 - 234.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Guan
Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2801 - 2815.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
H. Harant and I. J. D. Lindley
Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-{kappa}B
Nucleic Acids Res., October 5, 2004; 32(17): 5280 - 5290.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. L. DeCicco, T. Tanaka, F. Andreola, and L. M. De Luca
The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPAR{gamma} pathway
Carcinogenesis, October 1, 2004; 25(10): 1805 - 1812.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Kleemann, L. Verschuren, B.-J. de Rooij, J. Lindeman, M. M. de Maat, A. J. Szalai, H. M. G. Princen, and T. Kooistra
Evidence for anti-inflammatory activity of statins and PPAR{alpha} activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro
Blood, June 1, 2004; 103(11): 4188 - 4194.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Srinivasan, M. E. Hatley, K. B. Reilly, E. C. Danziger, and C. C. Hedrick
Modulation of PPAR{alpha} Expression and Inflammatory Interleukin-6 Production by Chronic Glucose Increases Monocyte/Endothelial Adhesion
Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 851 - 857.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. Gervois, R. Kleemann, A. Pilon, F. Percevault, W. Koenig, B. Staels, and T. Kooistra
Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-{alpha} Activator Fenofibrate
J. Biol. Chem., April 16, 2004; 279(16): 16154 - 16160.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. M. Weber, A. L. Scarim, and J. A. Corbett
PPAR{gamma} is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E329 - E336.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
M. Meissner, M. Stein, C. Urbich, K. Reisinger, G. Suske, B. Staels, R. Kaufmann, and J. Gille
PPAR{alpha} Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by Repressing Sp1-Dependent DNA Binding and Transactivation
Circ. Res., February 20, 2004; 94(3): 324 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. N. Muller, J. Theuer, E. Shagdarsuren, E. Kaergel, H. Honeck, J.-K. Park, M. Markovic, E. Barbosa-Sicard, R. Dechend, M. Wellner, et al.
A Peroxisome Proliferator-Activated Receptor-{alpha} Activator Induces Renal CYP2C23 Activity and Protects from Angiotensin II-Induced Renal Injury
Am. J. Pathol., February 1, 2004; 164(2): 521 - 532.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
W. A. Hsueh and D. Bruemmer
Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Hypertension, February 1, 2004; 43(2): 297 - 305.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Sartipy and D. J. Loskutoff
Expression Profiling Identifies Genes That Continue to Respond to Insulin in Adipocytes Made Insulin-resistant by Treatment with Tumor Necrosis Factor-{alpha}
J. Biol. Chem., December 26, 2003; 278(52): 52298 - 52306.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T.-l. Yue, W. Bao, B. M. Jucker, J.-l. Gu, A. M. Romanic, P. J. Brown, J. Cui, D. T. Thudium, R. Boyce, C. L. Burns-Kurtis, et al.
Activation of Peroxisome Proliferator-Activated Receptor-{alpha} Protects the Heart From Ischemia/Reperfusion Injury
Circulation, November 11, 2003; 108(19): 2393 - 2399.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
E. L. Schiffrin, F. Amiri, K. Benkirane, M. Iglarz, and Q. N. Diep
Peroxisome Proliferator-Activated Receptors: Vascular and Cardiac Effects in Hypertension
Hypertension, October 1, 2003; 42(4): 664 - 668.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Barbier, D. Duran-Sandoval, I. Pineda-Torra, V. Kosykh, J.-C. Fruchart, and B. Staels
Peroxisome Proliferator-activated Receptor {alpha} Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme
J. Biol. Chem., August 29, 2003; 278(35): 32852 - 32860.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Q. Yan, J. Zhang, H. Liu, S. Babu-Khan, R. Vassar, A. L. Biere, M. Citron, and G. Landreth
Anti-Inflammatory Drug Therapy Alters {beta}-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease
J. Neurosci., August 20, 2003; 23(20): 7504 - 7509.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
G. Woerly, K. Honda, M. Loyens, J.-P. Papin, J. Auwerx, B. Staels, M. Capron, and D. Dombrowicz
Peroxisome Proliferator-activated Receptors {alpha} and {gamma} Down-regulate Allergic Inflammation and Eosinophil Activation
J. Exp. Med., August 4, 2003; 198(3): 411 - 421.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Barbier, L. Villeneuve, V. Bocher, C. Fontaine, I. P. Torra, C. Duhem, V. Kosykh, J.-C. Fruchart, C. Guillemette, and B. Staels
The UDP-glucuronosylt